Commercial Excellence in Life Science: Planning for 2026

LINUS and SelectScience surveyed 644 scientists and 133 executives and uncovered some uncomfortable truths about life science commercial strategy. The findings reveal critical disconnects: executives believe sales relationships (34%) build trust, while scientists trust peer-reviewed content (42%) and independent sources (42%). Lead nurturing ranks as the least effective funnel stage, yet budget keeps flowing there. Trade shows deliver 61% effectiveness, the highest of any tactic, while over 40% of scientists say social media is "not applicable" at any buying stage.

Join Hamid Ghanadan (LINUS), Kerry Parker (SelectScience), Zoe Nilsson (bit.bio), and Kristine Friscino (Nuclera) as they reveal where budgets are being wasted, which channels scientists actually use, and how to realign your strategy before finalizing 2026 plans. With only 64% of executives confident they'll hit revenue targets and scientists' budgets growing, the gap between perception and reality is costing you deals.

Moderated by Annabel Sedgwick, SAMPS Board Member. Live Q&A included.